Two important issues are linked in the chemotherapy of tuberculosis. The first is to kill dividing bacilli in the shortest possible time to get bacteriological cure and prevent development of secondary resistance, and the second is to kill those persisting bacilli in order to avoid relapses and so achieve a permanent cure. The efficacy of short course chemotherapy potency and bacteriostatic depends exclusively agents on which its bactericidal have no role to play. Short course chemotherapy is based on the Concept that the drugs employed should have a dual bactericidal action i.e. both against metabolically active bacilli and also against persisters.